Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anyu Peibo Capsule for Major Depressive Disorder
CTR20170534Phase 3Completed
- Sponsor
- Suzhou YiHua Biomedical Technology
- Start
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of anyu peibo in major depressive disorder (MDD), sponsored by Suzhou YiHua Biomedical Technology. Started Jun 2017; status: completed.
02
Drugs
anyu peibo
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on CTR20170534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170534.